Release Date: 31/01/13 12:30 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 632.96KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%